Stem cell shot aims to halt diabetic kidney damage
NCT ID NCT07396155
Summary
This early-stage study is testing whether a single injection of umbilical cord stem cells directly into the kidney is safe and can help improve kidney function in people with diabetic kidney disease. Ten participants aged 40-65 will receive the injection and be monitored for a full year to check for side effects and measure changes in key kidney health markers. The goal is to see if this cell therapy can slow disease progression alongside standard medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHY TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dr. Sardjito General Hospital
RECRUITINGYogyakarta, 55284, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.